ResMed (RMD) Tops Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.59 -2.96%
EPS Growth %: +5.5%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.95, $0.06 better than the analyst estimate of $2.89. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.47 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Google: partnering with Nevoya & GMA
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
